AlcheraBio LLC announces partnership with Mindprint Inc. to move to a cloud-based custom enterprise software solution designed to improve productivity and drive future growth (Toronto, ON – Aug 20, 2013)

Written by Mindprint Admin on . Posted in News


AlcheraBio LLC Announces Partnership With Mindprint Inc. to Move to a Cloud-Based Custom Enterprise Software Solution Designed to Improve Productivity and Drive Future Growth

New Jersey/Toronto: AlcheraBio, a veterinary clinical contract research organization (CRO) based in New Jersey, and Mindprint Inc. of Markham, Ontario, have completed the implementation of a Custom Enterprise Software  System (ERP) that will dramatically improve AlcheraBio’s productivity, allocation of resources and plans for growth.

 AlcheraBio provides the most-up-date support to its clients in the animal health care, biotechnology and life sciences fields by delivering thorough, detailed services quickly.

 The implementation allows AlcheraBio to collate several systems to a “one-button push” system that is highly efficient. The system manages CRO operations such as study proposal management, study quotation, timesheets, expenses, invoicing, CRM, and HR.

 ”Now, we can clearly see where the company might gain efficiency, cut costs, or make additional investments into the business,” said Dr. Johnny Jacobsen, COO of AlcheraBio.  

 The partnership with Mindprint Inc., which designs, develops, and implements cloud-based software solutions for the Clinical Research market, provides something completely different from other solutions: an affordable, cloud-based front-to-back-end, fully customized enterprise software solution that fits the specific needs of AlcheraBio.

 “No two contract research organizations are the same, and they all have very complex requirements,” said Prasad A. Sristi, founder and president of Mindprint Inc. “With our Axpert based software, clients get our ‘hands-on’ systematic approach to helping them solve and manage their internal process challenges, and an attractive subscription package that does not require massive outlays of customer time or money. It provides them the flexibility they need as their organization grows and prospers,” he said.

 AlcheraBio said the Mindprint solution has already slashed project financial administration management time by nearly three quarters. The company now spends 7 to 8 hours a month (down from 32-36) collecting, aggregating and managing its financial data at month end. Besides harnessing its own internal processes, the technology has helped AlcheraBio offer up-to-date project cost numbers to its clients.

 “Transparency is so important in everything we do. Now there are no black holes,” said AlcheraBio’s COO Dr. Jacobsen.

 About AlcheraBio

AlcheraBio LLC is a leading veterinary clinical contract research organization (CRO) and animal health consultancy. AlcheraBio is headquartered in New Jersey, with a satellite office in Kansas City. AlcheraBio is a subsidiary of Argenta, a global formulations R&D and manufacturing company headquartered in New Zealand, with a newly opened R&D facility in Lawrence, Kansas. AlcheraBio is a comprehensive resource supporting many facets of the animal health industry. AlcheraBio has provided a variety of services for animal health companies, biotechnology and life sciences companies, and investors since their inception in April 2001. 

About Mindprint

Mindprint Inc. specializes in serving Contract Research Organizations and pharmaceutical companies with cloud-based enterprise software solutions that provide direct business benefits such as enhanced profitability, streamlined business processes and superior customer value. Headquartered in Markham, Ontario, Mindprint has partnered with a number of leading CROs and understands the life cycle of a clinical study as well as the business challenges and system requirements unique to the life sciences industry.



 For more information or to arrange an interview with AlcheraBio or Mindprint principals, contact:

 Judy Rudin

J. Rudin Communications

(604) 219-5168



Twitter response: "Could not authenticate you."